CYTK

NASDAQ 已收盘

Cytokinetics

51.46 USD
▲+0.14+0.27%
盘后 51.60 +0.27%
2026-11-19
市值
$7.23B
市盈率
—
EPS
-6.02
股息率
—
52 周区间
50.32 – 88.31
成交量
1.74M
Beta
0.47
目标价
109.42
52W 低 50.3252W 高 88.31
价格走势

公司简介

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in h...